Bridgewater Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-250,947	Closed	-$31.2M	–	659
2025 Q1	$31.2M	Buy	250,947 +58,912	+31%	+$7.69M	0.14%	128
2024 Q4	$23.6M	Buy	192,035 +79,036	+70%	+$9.32M	0.11%	143
2024 Q3	$12.6M	Buy	112,999 +11,864	+12%	+$1.3M	0.07%	229
2024 Q2	$10.8M	Sell	101,135 -8,656	-8%	-$952K	0.06%	242
2024 Q1	$13.2M	Buy	109,791 +19,375	+21%	+$2.37M	0.07%	215
2023 Q4	$11.1M	Buy	90,416 +2,640	+3%	+$329K	0.06%	230
2023 Q3	$11.4M	Buy	87,776 +76,599	+685%	+$10.2M	0.07%	220
2023 Q2	$1.39M	Buy	+11,177	New	+$1.5M	0.01%	529
2023 Q1	–	Sell	-3,373	Closed	-$537K	–	805
2022 Q4	$537K	Sell	3,373 -24,850	-88%	-$3.64M	﹤0.01%	714
2022 Q3	$3.76M	Buy	+28,223	New	+$4.29M	0.02%	441
2021 Q4	–	Sell	-2,200	Closed	-$286K	–	774
2021 Q3	$286K	Buy	+2,200	New	+$332K	﹤0.01%	639
2021 Q1	–	Sell	-2,255	Closed	-$372K	–	534
2020 Q4	$372K	Buy	+2,255	New	+$336K	﹤0.01%	485